casein-kinase-ii and Obesity

casein-kinase-ii has been researched along with Obesity* in 5 studies

Other Studies

5 other study(ies) available for casein-kinase-ii and Obesity

ArticleYear
Obesity-Linked Phosphorylation of SIRT1 by Casein Kinase 2 Inhibits Its Nuclear Localization and Promotes Fatty Liver.
    Molecular and cellular biology, 2017, 08-01, Volume: 37, Issue:15

    Sirtuin1 (SIRT1) deacetylase delays and improves many obesity-related diseases, including nonalcoholic fatty liver disease (NAFLD) and diabetes, and has received great attention as a drug target. SIRT1 function is aberrantly low in obesity, so understanding the underlying mechanisms is important for drug development. Here, we show that obesity-linked phosphorylation of SIRT1 inhibits its function and promotes pathological symptoms of NAFLD. In proteomic analysis, Ser-164 was identified as a major serine phosphorylation site in SIRT1 in obese, but not lean, mice, and this phosphorylation was catalyzed by casein kinase 2 (CK2), the levels of which were dramatically elevated in obesity. Mechanistically, phosphorylation of SIRT1 at Ser-164 substantially inhibited its nuclear localization and modestly affected its deacetylase activity. Adenovirus-mediated liver-specific expression of SIRT1 or a phosphor-defective S164A-SIRT1 mutant promoted fatty acid oxidation and ameliorated liver steatosis and glucose intolerance in diet-induced obese mice, but these beneficial effects were not observed in mice expressing a phosphor-mimic S164D-SIRT1 mutant. Remarkably, phosphorylated S164-SIRT1 and CK2 levels were also highly elevated in liver samples of NAFLD patients and correlated with disease severity. Thus, inhibition of phosphorylation of SIRT1 by CK2 may serve as a new therapeutic approach for treatment of NAFLD and other obesity-related diseases.

    Topics: Active Transport, Cell Nucleus; Animals; Casein Kinase II; Cell Nucleolus; Fatty Acids; Humans; Liver; Male; Mice, Inbred C57BL; Models, Molecular; Non-alcoholic Fatty Liver Disease; Obesity; Oxidation-Reduction; Phosphorylation; Sirtuin 1

2017
CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity.
    Scientific reports, 2017, 12-14, Volume: 7, Issue:1

    Insulin plays a major role in glucose metabolism and insulin-signaling defects are present in obesity and diabetes. CK2 is a pleiotropic protein kinase implicated in fundamental cellular pathways and abnormally elevated in tumors. Here we report that in human and murine adipocytes CK2-inhibition decreases the insulin-induced glucose-uptake by counteracting Akt-signaling and GLUT4-translocation to the plasma membrane. In mice CK2 acts on insulin-signaling in adipose tissue, liver and skeletal muscle and its acute inhibition impairs glucose tolerance. Notably, CK2 protein-level and activity are greatly up-regulated in white adipose tissue from ob/ob and db/db mice as well as from obese patients, regardless the severity of their insulin-resistance and the presence of pre-diabetes or overt type 2 diabetes. Weight loss obtained by both bariatric surgery or hypocaloric diet reverts CK2 hyper-activation to normal level. Our data suggest a central role of CK2 in insulin-sensitivity, glucose homeostasis and adipose tissue remodeling. CK2 up-regulation is identified as a hallmark of adipose tissue pathological expansion, suggesting a new potential therapeutic target for human obesity.

    Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue, White; Animals; Biological Transport; Casein Kinase II; Glucose; Humans; Insulin; Liver; Mice; Muscle, Skeletal; Obesity; Signal Transduction; Up-Regulation

2017
Phosphoproteomics Identifies CK2 as a Negative Regulator of Beige Adipocyte Thermogenesis and Energy Expenditure.
    Cell metabolism, 2015, Dec-01, Volume: 22, Issue:6

    Catecholamines promote lipolysis both in brown and white adipocytes, whereas the same stimuli preferentially activate thermogenesis in brown adipocytes. Molecular mechanisms for the adipose-selective activation of thermogenesis remain poorly understood. Here, we employed quantitative phosphoproteomics to map global and temporal phosphorylation profiles in brown, beige, and white adipocytes under β3-adrenenoceptor activation and identified kinases responsible for the adipose-selective phosphorylation profiles. We found that casein kinase2 (CK2) activity is preferentially higher in white adipocytes than brown/beige adipocytes. Genetic or pharmacological blockade of CK2 in white adipocytes activates the thermogenic program in response to cAMP stimuli. Such activation is largely through reduced CK2-mediated phosphorylation of class I HDACs. Notably, inhibition of CK2 promotes beige adipocyte biogenesis and leads to an increase in whole-body energy expenditure and ameliorates diet-induced obesity and insulin resistance. These results indicate that CK2 is a plausible target to rewire the β3-adrenenoceptor signaling cascade that promotes thermogenesis in adipocytes.

    Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Casein Kinase II; Cyclic AMP; Energy Metabolism; Histone Deacetylases; Ion Channels; Male; Mice; Mice, Inbred C57BL; Mitochondrial Proteins; Naphthyridines; Norepinephrine; Obesity; Oxides; Phenazines; Phosphopeptides; Proteomics; Receptors, Adrenergic, beta-3; Signal Transduction; Thermogenesis; Uncoupling Protein 1; Vanadium Compounds

2015
Genetic variation in the NOC gene is associated with body mass index in Chinese subjects.
    PloS one, 2013, Volume: 8, Issue:7

    Circadian clock genes are critical regulators of energy homeostasis and metabolism. However, whether variation in the circadian genes is associated with metabolic phenotypes in humans remains to be explored. In this study, we systemically genotyped 20 tag single nucleotide polymorphisms (SNPs) in 8 candidate genes involved in circadian clock, including CLOCK, BMAL1(ARNTL), PER1, PER2, CRY1, CRY2, CSNK1E,, and NOC(CCRN4L) in 1,510 non-diabetic Chinese subjects in Taipei and Yunlin populations in Taiwan. Their associations with metabolic phenotypes were analyzed. We found that genetic variation in the NOC gene, rs9684900 was associated with body mass index (BMI) (P = 0.0016, Bonferroni corrected P = 0.032). Another variant, rs135764 in the CSNK1E gene was associated with fasting glucose (P = 0.0023, Bonferroni corrected P = 0.046). These associations were consistent in both Taipei and Yunlin populations. Significant epistatic and joint effects between SNPs on BMI and related phenotypes were observed. Furthermore, NOC mRNA levels in human abdominal adipose tissue were significantly increased in obese subjects compared to non-obese controls.. Genetic variation in the NOC gene is associated with BMI in Chinese subjects.

    Topics: Adipose Tissue; Alleles; Asian People; Blood Glucose; Blood Pressure; Body Mass Index; Casein Kinase II; Female; Genetic Association Studies; Genetic Loci; Humans; Linkage Disequilibrium; Male; Metabolism; Middle Aged; Nuclear Proteins; Obesity; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Taiwan; Transcription Factors; Triglycerides

2013
Protein kinase CK2 is altered in insulin-resistant genetically obese (fa/fa) rats.
    FEBS letters, 1998, Oct-23, Volume: 437, Issue:3

    Hepatic insulin receptor levels in 6-week-old obese (fa/fa) rats were about 2-fold lower than those from lean (Fa/-) rats, which agrees with their insulin-resistant state. Nuclear protein kinase CK2 activity and protein content in livers from obese (fa/fa) rats were similar to those of lean (Fa/-) animals but the cytosolic levels were reduced to half, due to a decrease in the 39-kD)a catalytic subunit. Marked increases in activity, due to rises in the 44-kDa and 39-kDa catalytic subunits, were seen in the 16000 x g sediments (M1) from insulin-resistant rats, with moderate changes in the 100000xg sediments (M2). The increase in CK2 binding to M1 did not require increases in the molecular chaperone grp94, which was unaltered in insulin-resistant rats.

    Topics: Animals; Casein Kinase II; Chromatography, Affinity; Female; HSP70 Heat-Shock Proteins; Insulin Resistance; Lectins; Liver; Membrane Proteins; Obesity; Protein Serine-Threonine Kinases; Rats; Rats, Zucker; Receptor, Insulin; Sepharose; Subcellular Fractions

1998